US Stock MarketDetailed Quotes
BIIB Biogen
- 160.630
- +0.800+0.50%
Close Nov 29 13:00 ET
- 160.630
- 0.0000.00%
Post 17:02 ET
23.41BMarket Cap14.52P/E (TTM)
161.670High158.440Low1.11MVolume160.720Open159.830Pre Close178.27MTurnover0.76%Turnover Ratio20.15P/E (Static)145.72MShares268.29552wk High1.43P/B23.33BFloat Cap153.62052wk Low--Dividend TTM145.23MShs Float480.180Historical High--Div YieldTTM2.02%Amplitude2.625Historical Low160.663Avg Price1Lot Size
About Biogen Company
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Company Profile
SymbolBIIB
Company NameBiogen
Listing DateSep 17, 1991
Issue Price15.00
Founded1978
CEOMr. Christopher A. Viehbacher
MarketNASDAQ
Employees7570
Fiscal Year Ends12-31
Address225 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-679-2000
Websitehttp://www.biogen.com
Company Executives
- Name
- Position
- Salary
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 4.07M
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 7.17M
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- --
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 6.70M
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- 5.45M
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 5.71M
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Caroline D. Dorsa
- Chairman of the Board
- 646.13K
- Susan Langer
- Independent Director
- 334.53K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 418.02K
- Jesus B. Mantas
- Independent Director
- 433.23K
- Dr. Maria C. Freire, PhD
- Independent Director
- 412.90K
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Dr. Lloyd Minor
- Independent Director
- --
- Monish D. Patolawala
- Independent Director
- --
- William A. Hawkins, III
- Independent Director
- 425.73K
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 435.32K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
